help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 3, No. 3 547-551
doi:10.1210/mend-3-3-547
Copyright © 1989 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, D. G.
Right arrow Articles by Gagel, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, D. G.
Right arrow Articles by Gagel, R. F.

1,25-Dihydroxyvitamin D3 Silences 3',5'-Cyclic Adenosine Monophosphate Enhancement of Somatostatin Gene Transcription in Human Thyroid C Cells

Douglas G. Rogers, Gilbert J. Cote, Eileen S. C. Huang and Robert F. Gagel

Laboratory of Molecular and Cellular Endocrinology, Departments of Pediatrics, Medicine and Cell Biology, VA Medical Center and Baylor College of Medicine Houston, Texas 77030

Address requests for reprints to: Dr. Robert F. Gagel, Laboratory of Molecular and Cellular Endocrinology, VA Medical Center (111E), 2002 Holcombe Boulevard, Houston, Texas 77030.

Abstract

Treatment of the somatostatin (SRIF)-producing TT cell line with 1,25 dihydroxyvitamin D3 (1,25 D3) lowered intracellular SRIF mRNA and peptide concentration. In separate experiments, the cAMP analog 8-(4-chlorophenylthio)-cAMP stimulated a rapid increase in SRIF mRNA content of the TT cells and SRIF peptide secretion. To determine whether 1,25 D3 could inhibit either the transcriptional or secretory effects of cAMP, TT cells were pretreated with 1,25 D3 for 4 days followed by treatment with the cAMP analog. Pretreatment with 1,25 D3 inhibited the cAMP-mediated increase of SRIF mRNA, but had no effect on the secretory response. We conclude that the ability of 1,25 D3 to silence SRIF gene expression is more potent than cAMP enhancer activity but that 1,25 D3 has no effect on that portion of the cAMPdependent pathway which regulates peptide secretion.

FOOTNOTES

This work was supported by Career Development and Merit Review grants from the Veterans Administration.

Received for publication October 20, 1988. Revision received December 20, 1988. Accepted for publication December 21, 1988.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. A. Turman and C. A. Apple
Human proximal tubular epithelial cells express somatostatin: regulation by growth factors and cAMP
Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1095 - F1101.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society